Cullinan Associates’s Humana HUM Stock Holding History

Cullinan Associates’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$277K	Hold	1,600	–	–	0.02%	189
2025 Q4	$410K	Buy	1,600 +75	+5%	+$19.7K	0.03%	168
2025 Q3	$397K	Hold	1,525	–	–	0.03%	178
2025 Q2	$373K	Hold	1,525	–	–	0.02%	188
2025 Q1	$404K	Hold	1,525	–	–	0.03%	177
2024 Q4	$387K	Hold	1,525	–	–	0.02%	182
2024 Q3	$397K	Hold	1,525	–	–	0.02%	194
2024 Q2	$570K	Hold	1,525	–	–	0.03%	176
2024 Q1	$529K	Hold	1,525	–	–	0.03%	183
2023 Q4	$698K	Hold	1,525	–	–	0.04%	166
2023 Q3	$742K	Hold	1,525	–	–	0.04%	159
2023 Q2	$682K	Hold	1,525	–	–	0.04%	176
2023 Q1	$740K	Hold	1,525	–	–	0.04%	172
2022 Q4	$781K	Hold	1,525	–	–	0.04%	174
2022 Q3	$740K	Hold	1,525	–	–	0.05%	160
2022 Q2	$714K	Hold	1,525	–	–	0.04%	155
2022 Q1	$664K	Hold	1,525	–	–	0.03%	165
2021 Q4	$707K	Hold	1,525	–	–	0.04%	160
2021 Q3	$593K	Hold	1,525	–	–	0.03%	169
2021 Q2	$675K	Hold	1,525	–	–	0.04%	152
2021 Q1	$639K	Hold	1,525	–	–	0.04%	144
2020 Q4	$626K	Hold	1,525	–	–	0.04%	136
2020 Q3	$631K	Sell	1,525 -75	-5%	-$30.2K	0.04%	131
2020 Q2	$620K	Hold	1,600	–	–	0.04%	131
2020 Q1	$502K	Buy	+1,600	New	+$540K	0.04%	128

Other funds holding HUM

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Cullinan Associates's HUM Position: Q1 2026 in Review

Cullinan Associates held its Humana (HUM) position steady in Q1 2026 at 1,600 shares worth $277K. The position accounts for 0.02% of the portfolio, ranked #189.

Cullinan Associates first reported a position in HUM in Q1 2020 and has held it in 25 quarters since. The position peaked at $781K in Q4 2022. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

Cullinan Associates held 1,600 shares of Humana worth $277K as of Q1 2026.
Cullinan Associates left its Humana share count unchanged in Q1 2026.
Humana made up 0.02% of Cullinan Associates's portfolio in Q1 2026, its #189 holding.
Cullinan Associates first reported a position in Humana in Q1 2020 and has held it in 25 quarters since.
Cullinan Associates's Humana position peaked at $781K in Q4 2022.
779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.